Since GPX4 is one of the main defense mechanisms against lipid peroxidation and is the principal regulator of ferroptosis, authors believe that metformin induces ferroptosis in breast cancer cells through the regulation of the miR-324-3p—GPX4 signaling pathway. This evidence concerns the gene GPX4 and breast carcinoma.